- Home
- CMCL vs MYGN Comparison
CMCL vs MYGN Comparison
Compare CMCL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCL | MYGN |
|---|---|---|
| Founded | 1992 | 1991 |
| Country | Jersey | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.3M | 444.2M |
| IPO Year | 2003 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CMCL | MYGN |
|---|---|---|
| Price | $23.65 | $4.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $28.00 | $7.64 |
| AVG Volume (30 Days) | 206.9K | ★ 1.6M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $771,400,000.00 |
| Revenue This Year | $35.51 | $6.89 |
| Revenue Next Year | N/A | $5.35 |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | N/A | ★ 2.33 |
| 52 Week Low | $11.11 | $3.76 |
| 52 Week High | $38.75 | $8.59 |
Technical Indicators
Market Signals| Indicator | CMCL | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.25 | 49.42 |
| Support Level | $23.10 | $4.23 |
| Resistance Level | $24.49 | $5.69 |
| Average True Range (ATR) | 1.24 | 0.28 |
| MACD | 0.31 | 0.03 |
| Stochastic Oscillator | 82.13 | 60.60 |
Price Performance
Historical ComparisonAbout CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.